Our research group is headed by Professor Kevin Booker-Milburn and our research interests include photochemistry, palladium (II) catalysis and natural product total synthesis. We are based in the School of Chemistry in the University of Bristol.

Professor Kevin Booker-Milburn is Director of the Bristol Chemical Synthesis Doctoral Training Centre with which we closely collaborate.

A modified version of our original FEP Photochemical Flow Reactor (DOI) has been used by Seeberger & Levesque in a stunning continuous-flow synthesis of the front-line anti-malaria drug Artemisinin (DOI). As reported the complete integrated flow system can synthesize more the 200 g per day of this life saving drug and 400 such reactor systems could provide the current world's supply of Artemisinin required to treat the disease.

For previous news click here.

Switching Pathways: Room-Temperature Neutral Solvolysis and Substitution of Amides; Marc Hutchby, Chris E. Houlden, Mairi F. Haddow, Simon N. G. Tyler, Guy C. Lloyd-Jones, Kevin I. Booker-Milburn Angew. Chem. Int. Ed. DOI.

For previous publications click here.